Keywords: اقدام ضد ویروسی مستقیم; ALT; Alanine Aminotransferase; AST; Aspartate Aminotransferase; BMT; Bone Marrow Transplantation; DAA; Direct-Acting Antiviral; DILI; Drug Induced Liver Injury; GVHD; Graft Versus Host Disease; HAI; Hepatic Activity Index; HCV; Hepatitis C Virus; MRI; Mag
مقالات ISI اقدام ضد ویروسی مستقیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اقدام ضد ویروسی مستقیم; anti-infectives; bioavailability; clinical pharmacokinetics; formulation; oral absorption; pharmacokinetics; HCV; hepatitis C virus; GT; genotype; DAA; direct-acting antiviral; RBV; ribavirin; GLE; glecaprevir; PIB; pibrentasvir; Cmax; maximum plasma conc
Keywords: اقدام ضد ویروسی مستقیم; BNab; broadly neutralising antibody; CTL; cytotoxic lymphocyte; DAA; direct-acting antiviral; HBV; hepatitis B virus; HCV; hepatitis C virus; HIV; human immunodeficiency virus; NGS; next generation sequencing; SGA; single genome amplification; SNP; single
Keywords: اقدام ضد ویروسی مستقیم; Cost Effectiveness; Budget Impact; Public Health; Health Care Expenses; CEA; cost-effectiveness analysis; CHEERS; The Consolidated Health Economic Evaluation Reporting Standards; DAA; direct-acting antiviral; HCV; hepatitis C virus; ICER; incremental cost
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; RNA; Ribonucleic Acid; RT-PCR; Reverse-transcriptase Polymerase Chain Reaction; DNA; Deoxyribonucleic Acid; IFN; interferon; RBV; ribavirin; PEG; pegylated; DAA; direct-acting antiviral; SVR; sustained viral response; Hepatitis C;
Keywords: اقدام ضد ویروسی مستقیم; Cryoglobulins; Insulin Resistance; Cardiovascular Risk; Fatigue; Health-Related Quality of Life; anti-HCV; antibodies to hepatitis C virus; CI; confidence interval; CNS; central nervous system; DAA; direct-acting antiviral; HBV; hepatitis B virus; HCC; he
Keywords: اقدام ضد ویروسی مستقیم; DAA; direct-acting antiviral; HCV; hepatitis C virus; SVR; sustained virologic response; PR; peginterferon plus ribavirin; EPO; erythropoietin; BMI; body mass index; Hb; hemoglobin; ROC; receiver-operator characteristic; CI; confidence interval; OR; odds
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Hepatitis C virus infection spontaneous clearance: Has it been underestimated?
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; PWID; people who inject drugs; RNA; ribonucleic acid; Ab; HCV antibody; SM; supplementary material; EDHS; Egypt Demographic and Health Surveys; NHANES; National Health and Nutrition Examination Surveys; CI; Confidence Interval; UI;
Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment
Keywords: اقدام ضد ویروسی مستقیم; Chronic hepatitis C; Lipid; Apolipoprotein; Therapy; Direct-acting antiviral;
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting Antiviral; DAA; Short-duration; Pangenotypic; ALT; alanine aminotransferase; CI; confidence interval; DAA; direct-acting antiviral; G/P; glecaprevir/pibrentasvir; HCV; hepatitis C virus; IFN; interferon; ITT; intention-to-treat; LLOQ; lower
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C virus; Human immunodeficiency virus-1; Direct-acting antiviral; T-cell; Immune activation; Intracellular cytokine assay;
Hepatitis C Care in the Department of Veterans Affairs
Keywords: اقدام ضد ویروسی مستقیم; Veterans; Direct-acting antiviral; SVR; Hepatitis C; Population health; Innovation; System redesign;
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C; Comorbidities; Cirrhosis; Sustained viral response; Direct-acting antiviral; Mortality; Real-world cohort;
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C; Direct-acting antiviral; DAA; Injecting drug use; HIV; Reinfection;
Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting antiviral; Elimination; Hepatitis C virus; Iceland; Mathematical model; People who inject drugs; Testing;
Sofosbuvir/velpatasvir for 12â¯weeks in genotype 1-4 HCV-infected liver transplant recipients
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting antiviral; Hepatitis C; Liver transplant; NS5A inhibitor; Sofosbuvir; Velpatasvir;
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C; Short duration; Direct-acting antiviral; Pangenotypic;
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection
Keywords: اقدام ضد ویروسی مستقیم; MELD; BMI; Prognostic; Biomarker; ALT; alanine aminotransferase; AUROC; area under the receiver operative curve; BMI; body mass index; CI; confidence interval; CPT; Child-Pugh-Turcotte score; DAA; direct-acting antiviral; GFR; glomerulus filtration rate;
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Keywords: اقدام ضد ویروسی مستقیم; HCV; RASs; DAA; Virologic Treatment Failure; DAA; direct-acting antiviral; DCV; daclatasvir; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; NS; nonstructural protein; PCR; polymerase chain reaction; PEG IFN; pegylated interf
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: اقدام ضد ویروسی مستقیم; AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C virus; HCV; Tacrolimus; Direct-acting antiviral; CYP3A4;
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses
Keywords: اقدام ضد ویروسی مستقیم; DAA; direct-acting antiviral; EASL; European Association for the Study of the Liver; EFTA; European Free Trade Association; ELPA; European Liver Patients' Association; EU; European Union; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PWID;
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice
Keywords: اقدام ضد ویروسی مستقیم; Co-infection; Direct-acting antiviral; Hepatitis B; Hepatitis C; Reactivation;
Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B
Keywords: اقدام ضد ویروسی مستقیم; Aged patients; Chronic hepatitis C; Direct-acting antiviral; Sustained virologic response; Tolerability;
Polymorphisms associated with resistance to protease inhibitors in naïve patients infected with hepatitis C virus genotype 1 in Argentina: Low prevalence of Q80K
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C virus; Resistance; NS3; Direct-acting antiviral; Protease inhibitor; Q80K;
A profiling study of a newly developed HCVcc strain PR63cc's sensitivity to direct-acting antivirals
Keywords: اقدام ضد ویروسی مستقیم; HCV; DAA; Drug resistance; HCVcc; Resistance-associated variants; HCV; Hepatitis C virus; DAA; Direct-acting antiviral; RAV; Resistance-associated variant; SVR; Sustained virologic response; HCVcc; Hepatitis C virus cell culture system; ORF; Open reading
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting antiviral; Pangenotypic; ABT-493; ABT-530; SURVEYOR; D-alanine transaminase; Sustained virologic response; Hepatitis C, chronic; Liver cirrhosis; Interferons; Genotype;
Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C; Interferon; Direct-acting antiviral; Resistant; HCV; hepatitis C virus; DAA; direct-acting antiviral; RASs; resistance-associated substitutions; IFN; interferon; NS; nonstructural; uPA/SCID; immunodeficient urokinase-type plasminogen activato
Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C virus; Carbosilane dendrimer; Antiviral; Nanotechnology; Virucidal; HCV; hepatitis C virus; DAA; direct-acting antiviral; PCD; polyanionic carbosilane dendrimer; MSM; men who have sex with men; SVR; sustained virological response; HIV; human i
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade
Keywords: اقدام ضد ویروسی مستقیم; AU$; Australian dollar; APRI; AST to platelet ratio index; DAA; direct-acting antiviral; DC; decompensated cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; NSP; needle and syringe program; OST; opioid substitution therapy; PBS; Pharmaceut
Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España
Keywords: اقدام ضد ویروسی مستقیم; Antivirales de acción directa; Hepatitis C crónica; Plan estratégico para el abordaje de la hepatitis C; Análisis coste-efectividad.; Direct-acting antiviral; Chronic hepatitis C; National Strategic Plan for Hepatitis C; Cost-effectiveness analysis.;
Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting antiviral; Chronic hepatitis C; National strategic plan for hepatitis C; Cost-effectiveness analysis; Antivirales de acción directa; Hepatitis C crónica; Plan estratégico para el abordaje de la hepatitis C; Análisis coste-efectividad;
Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals
Keywords: اقدام ضد ویروسی مستقیم; Cryoglobulinemic Vasculitis; Hepatitis C; DAA; Antiviral Therapy; ACC; asymptomatic circulating cryoglobulins; BVAS.v3; Birmingham Vasculitis Activity Score version 3; C4; complement 4 fraction; CH50; 50% hemolytic complement activity; CV; cryoglobulinemi
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis
Keywords: اقدام ضد ویروسی مستقیم; DAA; Cryoglobulinemia Vasculitis; Autoimmunity; Treg Cell; CryoVas; cryoglobulinemia vasculitis; DAA; direct-acting antiviral; HCV; hepatitis C virus; IFN; interferon; SVR; sustained virologic response;
Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation
Keywords: اقدام ضد ویروسی مستقیم; Viral Hibernation; Treatment Outcome; Persistence; Limit of Detection; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BNR; biochemical nonresponder; DAA; direct-acting antiviral; HCV; hepatitis C virus; OCI; occult HCV infection; OLT; ort
Polymorphisms of chemokine receptor genes and clearance of hepatitis C virus infection in Chinese population
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; PEG; pegylated; RBV; ribavirin; SNPs; single nucleotide polymorphisms; SVR; sustained virological response; HWE; Hardy-Weinberg equilibrium; ALT; alanine aminotransferase; AST; aspartate aminotransferase; AFP; alpha fetal protein;
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis
Keywords: اقدام ضد ویروسی مستقیم; PDCD1; Immune Regulation; Response To Treatment; Liver Disease; BAFF; B-cell-activating factor of the tumor necrosis factor family; BR3; B-lymphocyte stimulator receptor 3; CV; cryoglobulinemia vasculitis; DAA; direct-acting antiviral; EOT; end of treat
Current therapy for chronic hepatitis C: The role of direct-acting antivirals
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting antivirals; NS3/4A drugs; NS5A drugs; NS5B drugs; BID; twice a day; CDC; Centers for Disease Control and Prevention; DAA; direct-acting antiviral; EC50; half maximal effective concentration; FDA; U S Food and Drug Administration; GT; genotyp
Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis
Keywords: اقدام ضد ویروسی مستقیم; Comparative Effectiveness; Mixed Treatment Comparison; NS5A Inhibitor; NS5B Inhibitor; CrI; credible interval; DAA; direct-acting antiviral; HCV; hepatitis C virus; MCMC; Markov Chain Monte Carlo; OR; odds ratio; RCT; randomized clinical trial; SVR; susta
Research ArticleBoceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients
Keywords: اقدام ضد ویروسی مستقیم; MSM; men having sex with men; HCV; hepatitis C virus; AHCV; acute hepatitis C virus; PegIFN; pegylated interferon; SVR; sustained virological response; RBV; ribavirin; DAA; direct-acting antiviral; DAHHS; Dutch Acute HCV in HIV Study; cART; combination an
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
Keywords: اقدام ضد ویروسی مستقیم; Direct-acting antiviral; Hepatitis C; Liver biopsy; Non-invasive markers; Pegylated interferon;
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; DAA; direct-acting antiviral; MELD; model for end-stage liver disease; SVR; sustained virological response; EAP; expanded access programme; HCVRUK; hepatitis C Research UK; SOF; sofosbuvir; LDV; ledipasvir; DCV; daclatasvir; RBV; r
Research ArticleSustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12Â weeks
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; GT; genotype; SVR; sustained virologic response; SVR12; sustained virologic response 12Â weeks post-treatment; PegIFN; pegylated interferon; RBV; ribavirin; DAA; direct-acting antiviral; OBV; ombitasvir; PTV; paritaprevir; r; riton
Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis
Keywords: اقدام ضد ویروسی مستقیم; Hepatitis C virus; Gerontology; Cirrhosis; Sofosbuvir; Ribavirin; DAA; HCV; hepatitis C virus; PEG-IFNα; pegylated interferon alpha; DAA; direct-acting antiviral; ITPA; inosine triphosphate pyrophosphatase; eGFR; estimated glomerular filtration rate; IL2
Original ResearchFull Report: Clinical-LiverEfficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Keywords: اقدام ضد ویروسی مستقیم; NS5A Inhibitor; NS3/4A Protease Inhibitor; RUBY-I; Renal Disease; AE; adverse event; CKD; chronic kidney disease; Ctrough; steady-state trough concentration; DAA; direct-acting antiviral; DSV; dasabuvir; eGFR; estimated glomerular filtration rate; ESRD; e
Research ArticlePrioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; PWID; people who inject drugs; PegIFN; pegylated interferon; RBV; ribavirin; IFN-free; interferon-free; DAA; direct-acting antiviral; HCC; hepatocellular carcinoma; QALY; quality adjusted life-year; NMB; net monetary benefit; ESLD;
ReviewIdeal oral combinations to eradicate HCV: The role of ribavirin
Keywords: اقدام ضد ویروسی مستقیم; HCV; hepatitis C virus; SVR; sustained virological response; RBV; ribavirin; IFN; interferon; Peg-IFN; pegylated interferon; DAA; direct-acting antiviral; ALT; alanine transaminase; GTP; guanosine triphosphate; IMPDH; inosine monophosphate dehydrogenase;
HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial
Keywords: اقدام ضد ویروسی مستقیم; BL; baseline; BLQ; below limit of quantification; BN; Bayesian network; (c)DNA; (copy) deoxyribonucleic acid; CsA; cyclosporine A; DAA; direct-acting antiviral; dN; non-synonymous nucleotide change; dS; synonymous nucleotide change; EC50; half maximal eff
NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
Keywords: اقدام ضد ویروسی مستقیم; ALT; alanine aminotransferase; AST; aspartate aminotransferase; cART; combination antiretroviral therapy; DAA; direct-acting antiviral; DDI; drug-drug interaction; EOTR; end-of-treatment response; GT; genotype; HCV; hepatitis C virus; HIV-1; human immun